145773-08-6

Basic information

• Product Name: allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside
• Synonyms: allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside
• CAS NO: 145773-08-6
• Molecular Weight: 488.58
• Mol File: 145773-08-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside(145773-08-6)
• EPA Substance Registry System: allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside(145773-08-6)

Safety Data

• Hazardous Substances Data: 145773-08-6(Hazardous Substances Data)

Upstream product

• 100-44-7 benzyl chloride 
• 1056479-53-8 allyl-4,6-O-benzylidene-2,3-di-O-hydroxy-D-mannopyranoside 
• 530-26-7 D-Mannose 
• 4163-65-9 per-O-acetyl-α-D-mannopyranose 
• 100-39-0 benzyl bromide 
• 20746-64-9 allyl (R)-4,6-O-benzylidene-β-D-gluco-pyranoside 
• 492-61-5 β-D-glucose 
• 214490-84-3 Allyl 2,3,4,6-Tetra-O-acetyl-D-mannopyranoside 
• 119111-33-0 (3aS,5aR,8R,9aR,9bS)-4-Allyloxy-2,8-diphenyl-hexahydro-[1,3]dioxolo[4',5':4,5]pyrano[3,2-d][1,3]dioxine 
• 618-31-5 benzylidene dibromide 
• 182212-07-3 α,β-O-allyl-D-mannopyranoside 
• 10343-15-4 Acetic acid (2R,3R,4S,5R,6R)-3,5-diacetoxy-2-acetoxymethyl-6-allyloxy-tetrahydro-pyran-4-yl ester 
• 604-69-3 β-D-glucose pentaacetate 
• 1125-88-8 benzaldehyde dimethyl acetal 

Downstream Products

• 912651-00-4 2,3,6-tri-O-benzyl-D-mannono-1,5-lactone 
• 912650-53-4 3,4,5,7-tetra-O-benzyl-1-deoxy-α-D-gluco-hept-2-ulosyl-(2->4)-2,3,6-tri-O-benzyl-D-mannono-1,5-lactone 
• 912650-56-7 3,4,5,7-tetra-O-benzyl-1-deoxy-α-D-galacto-hept-2-ulosyl-(2->4)-2,3,6-tri-O-benzyl-D-mannono-1,5-lactone 
• 912650-59-0 3,4,5,7-tetra-O-benzyl-1-deoxy-α-D-manno-hept-2-ulosyl-(2->4)-2,3,6-tri-O-benzyl-D-mannono-1,5-lactone 
• 119237-94-4 <2R-(2α,4aβ,5α,6β,7β,7aβ)>-Hexahydro-5-methyl-2-phenyl-6,7-bis(phenylmethoxy)cyclopenta-1,3-dioxin 
• 119237-95-5 <2R-(2α,4aβ,5β,6β,7β,7aβ)>-Hexahydro-5-methyl-2-phenyl-6,7-bis(phenylmethoxy)cyclopenta-1,3-dioxin 
• 119237-93-3 (R)-1,2-Dideoxy-3,4-bis-O-(phenylmethyl)-5,7-O-(phenylmethylene)-D-manno-hept-1-enitol 
• 119111-10-3 Imidazole-1-carbothioic acid O-[(2R,4R,5R)-4-((1R,2R)-1,2-bis-benzyloxy-but-3-enyl)-2-phenyl-[1,3]dioxan-5-yl] ester 
• 760178-19-6 1-O-allyl-2,3-di-O-benzyl-6-O-tosyl-β-D-glucose 
• 760178-20-9 1-O-allyl-2,3-di-O-benzyl-4-O-(carbobenzoxy-β-alanyl)-6-O-tosyl-β-D-glucopyranoside 
• 760178-21-0 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-6-allyloxy-4,5-bis-benzyloxy-tetrahydro-pyran-3-yl ester 
• 760178-22-1 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-4,5-bis-benzyloxy-6-(2,3-dihydroxy-propoxy)-tetrahydro-pyran-3-yl ester 
• 1234307-27-7 C₅₄H₇₇NO₁₂S 
• 760178-23-2 Octadecanoic acid 2-[(2R,3R,4S,5S,6S)-6-acetylsulfanylmethyl-3,4-bis-benzyloxy-5-(3-benzyloxycarbonylamino-propionyloxy)-tetrahydro-pyran-2-yloxy]-1-octadecanoyloxymethyl-ethyl ester 

Relevant articles and documents

Preparation method of fondaparinux sodium disaccharide intermediate

The invention discloses a preparation method of fondaparinux sodium disaccharide intermediate. 1-O-substituent sulfonyl-2,3-bis-O-benzyl-4,6-O-benzylidene-beta-D-glucopyranose directly reacts with 1,6-dehydrated-2-deoxy-2-azido-3-O-acetyl-beta-D-glucopyranose to prepare the fondaparinux sodium disaccharide intermediate as shown in a formula I; and meanwhile, the fondaparinux sodium intermediate asshown in the formula I can be used as a raw material to synthesize fondaparinux sodium intermediate as shown in a formula IV. The preparation method is simple and small in steps, the yield is high, the atomic utilization rate is high, the three wastes are small, and the preparation method is suitable for industrial large-scale production. Please see the description for the formula.

COMPOUND RETAINED IN TUMOR

A novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treating tumor with use thereof are provided. The present invention relates to a compound represented by chemical formula (I) wherein R is an anionic group binding to hydrogen, R1 is OH, OCOH, OCO(CH2)hCH3, or an acting group, h being an integer of 0 or more, R2 is H, OH, OCOH, OCO(CH2)iCH3, or an acting group, i being an integer of 0 or more, R3 is OH, SO3H, or an acting group, R4 is OH, SO3H, or an acting group, and R5 is OH, SO3H, or an acting group, at least one of R1, R2, R3, R4, and R5 containing an acting group, or pharmaceutically acceptable salts thereof.

Synthesis of mono- and disaccharide analogs of moenomycin and lipid II for inhibition of transglycosylase activity of penicillin-binding protein 1b

Three types of mono- and disaccharides as well as some chaetomellic acid A analogs were synthesized and evaluated for inhibitory activity against the E. coli transglycosylase PBP1b. Three types of mono- and disaccharides 3a,b, 4a-c, 5, and some chaetomell